Salk scientists receive 2022 Mark Foundation Endeavor Award to study lung cancer

LA JOLLA—Professors Reuben Shaw, Susan Kaech, Christian Metallo and Alan Saghatelian have received a 2022 Mark Foundation for Cancer Research Endeavor Award to support their research exploring the metabolic changes that help lung cancers develop. The $3 million Endeavor Award promotes collaborative science to tackle some of the toughest challenges in cancer research. The Salk team—one of four teams chosen out of nearly 200 applications submitted by institutions around the world—hopes their work will lead to the development of more effective lung cancer treatments.

“New therapies for difficult-to-treat solid tumors like lung cancer are urgently needed,” says Shaw, head investigator on the project, who is also William R. Brody Chair and director of the Salk’s National Cancer Institute-designated Cancer Center. “This Endeavor award will accelerate our efforts to identify novel metabolic targets and develop precision drugs for specific genetic subsets of non-small cell lung cancer.”

Click here to view original post